DUBLIN, May 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/j6xn2m/blood_culture) has announced the addition of the "Blood Culture Test Market by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, Reference Laboratory, Clinical Laboratory, Academic Research Institute) - Forecast to 2019" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The blood culture test market is driven by several factors such as increasing blood stream infections (BSI), rising demand for rapid diagnostic tests, growing aging population, increase in healthcare expenditure and rising prevalence of infectious diseases which in turn creates demand for blood culture tests. The relatively untapped Asian market and the increasing demand for rapid diagnostic techniques have opened an array of opportunities for the growth of the blood culture market. However, high cost of automated blood culture instruments and lack of adequate reimbursement are likely to hinder the growth of this market.
The blood culture test market is segmented on the basis of methods, products, applications, end users, and regions. On the basis of methods, the blood culture test market is segmented into conventional/manual blood culture and automated blood culture. The automated blood culture segment is expected to grow at the highest CAGR from 2014 to 2019. The high growth of the segment is attributed to the increasing demand for rapid diagnostic tests for obtaining quick results over a short duration of time.
On the basis of products, the blood culture test market is bifurcated into consumables and instruments. The consumables segment is further segmented into blood culture bottles, reagents and assay kits, and other consumables. In 2014, the blood culture bottles segment accounted for the largest share of the blood culture market. The high growth of this segment can be attributed to the rising prevalence of blood stream infections (BSI) and infectious diseases.
On the basis of applications, the blood culture test market is segmented into aerobic blood culture, anaerobic blood culture, and yeast/fungi blood culture. In 2014, the aerobic blood culture segment accounted for the largest share of the blood culture market. The high share of this market is due to the increasing blood stream infections (BSI) and rising prevalence of infectious diseases.
On the basis of end users, the blood culture test market is segmented into hospital laboratories, clinical laboratories, reference laboratories, academic research laboratories, and other laboratories such as physician office laboratories, emergency departments (ICUs), and independent research laboratories. The reference laboratories segment is expected to grow at the highest CAGR from 2014 to 2019.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Blood Culture Test Market, By Method
8 Blood Culture Test Market, By Product Type
9 Blood Culture Test Market, By Application
10 Blood Culture Test Market, By End User
11 Geographic Analysis
12 Competitive Landscape
13 Company Profiles
- Abbott Laboratories
- Alere, Inc.
- Becton, Dickinson and Company
- Biomérieux SA
- Bruker Corporation
- Cepheid, Inc
- F. Hoffmann-La Roche Ltd.
- Nanosphere, Inc
- Siemens AG
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/j6xn2m/blood_culture
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article